Search Result |
Top |
Entry | Name | Description | Category | Pathway | Gene |
---|---|---|---|---|---|
H00011 | Lymphoplasmacytic lymphoma | ... marrow, lymph nodes, and the spleen. WM can be distinguished clinically from LPL on the basis of a detectable IgM monoclonal spike in serum. In the general population, LPL/WM is a very rare disease, accounting ... | Cancer | Pax5-IgH (translocation) [HSA:5079] [KO:K09383] | |
H00258 |
Aldosterone synthase deficiency Corticosterone methyloxidase type I deficiency Corticosterone methyloxidase type II deficiency |
... life-threatening salt-loss, failure to thrive, hyponatraemia and hyperkalaemia in early infancy. In type I deficiency, aldosterone is undetectable, whereas in type II aldosterone can be low or normal. | Endocrine and metabolic disease | CYP11B2 [HSA:1585] [KO:K07433] | |
H00604 | Deafness, autosomal dominant | Hereditary deafness is divided into syndromic forms (in which hearing loss is associated with a variety of other anomalies) and non-syndromic forms. Non-syndromic forms are responsible for 70% of the cases ... | Nervous system disease |
(DFNA1) DIAPH1 [HSA:1729] [KO:K05740] (DFNA2A) KCNQ4 [HSA:9132] [KO:K04929] (DFNA2B) GJB3 [HSA:2707] [KO:K07622] (DFNA3A) GJB2 [HSA:2706] [KO:K07621] (DFNA3B) GJB6 [HSA:10804] [KO:K07625] (DFNA4A) MYH14 [HSA:79784] [KO:K10352] (DFNA4B) CEACAM16 [HSA:388551] [KO:K06499] (DFNA5) GSDME [HSA:1687] [KO:K22146] (DFNA6/14/38) WFS1 [HSA:7466] [KO:K14020] (DFNA7) LMX1A [HSA:4009] [KO:K09371] (DFNA8/12) TECTA [HSA:7007] [KO:K18273] (DFNA9) COCH [HSA:1690] [KO:K23574] (DFNA10) EYA4 [HSA:2070] [KO:K17622] (DFNA11) MYO7A [HSA:4647] [KO:K10359] (DFNA13) COL11A2 [HSA:1302] [KO:K19721] (DFNA15) POU4F3 [HSA:5459] [KO:K09366] (DFNA17) MYH9 [HSA:4627] [KO:K10352] (DFNA20/26) ACTG1 [HSA:71] [KO:K05692] (DFNA22) MYO6 [HSA:4646] [KO:K10358] (DFNA23) SIX1 [HSA:6495] [KO:K15614] (DFNA25) SLC17A8 [HSA:246213] [KO:K12302] (DFNA27) REST [HSA:5978] [KO:K09222] (DFNA28) GRHL2 [HSA:79977] [KO:K09275] (DFNA34) NLRP3 [HSA:114548] [KO:K12800] (DFNA36) TMC1 [HSA:117531] [KO:K21988] (DFNA37) COL11A1 [HSA:1301] [KO:K19721] (DFNA39) DSPP [HSA:1834] [KO:K23573] (DFNA40) CRYM [HSA:1428] [KO:K18258] (DFNA41) P2RX2 [HSA:22953] [KO:K05216] (DFNA44) CCDC50 [HSA:152137] [KO:K25949] (DFNA50) MIR96 [HSA:407053] [KO:K17114] (DFNA56) TNC [HSA:3371] [KO:K06252] (DFNA64) DIABLO [HSA:56616] [KO:K10522] (DFNA65) TBC1D24 [HSA:57465] [KO:K21841] (DFNA66) CD164 [HSA:8763] [KO:K06546] (DFNA67) OSBPL2 [HSA:9885] [KO:K20174] (DFNA68) HOMER2 [HSA:9455] [KO:K15010] (DFNA69) KITLG [HSA:4254] [KO:K05461] (DFNA70) MCM2 [HSA:4171] [KO:K02540] (DFNA71) DMXL2 [HSA:23312] [KO:K24155] (DFNA72) SLC44A4 [HSA:80736] [KO:K15377] (DFNA73) PTPRQ [HSA:374462] [KO:K16910] (DFNA74) PDE1C [HSA:5137] [KO:K13755] (DFNA75) TRRAP [HSA:8295] [KO:K08874] (DFNA76) PLS1 [HSA:5357] [KO:K17275] (DFNA77) ABCC1 [HSA:4363] [KO:K05665] (DFNA78) SLC12A2 [HSA:6558] [KO:K10951] (DFNA79) SCD5 [HSA:79966] [KO:K00507] (DFNA80) GREB1L [HSA:80000] [KO:K27478] (DFNA81) ELMOD3 [HSA:84173] [KO:K23538] (DFNA82) ATP2B2 [HSA:491] [KO:K05850] (DFNA83) MAP1B [HSA:4131] [KO:K10429] (DFNA84) ATP11A [HSA:23250] [KO:K26934] (DFNA85) USP48 [HSA:84196] [KO:K11858] (DFNA86) THOC1 [HSA:9984] [KO:K12878] (DFNA87) PI4KB [HSA:5298] [KO:K19801] (DFNA88) EPHA10 [HSA:284656] [KO:K08897] (DFNA89) ATOH1 [HSA:474] [KO:K09083] (DFNA90) MYO3A [HSA:53904] [KO:K08834] |
|
H00605 | Deafness, autosomal recessive | Hereditary deafness is divided into syndromic forms (in which hearing loss is associated with a variety of other anomalies) and non-syndromic forms. Non-syndromic forms are responsible for 70% of the cases ... | Nervous system disease |
(DFNB1A) GJB2 [HSA:2706] [KO:K07621] (DFNB1A) GJB3 [HSA:2707] [KO:K07622] (DFNB1B) GJB6 [HSA:10804] [KO:K07625] (DFNB2) MYO7A [HSA:4647] [KO:K10359] (DFNB3) MYO15A [HSA:51168] [KO:K10361] (DFNB4) SLC26A4 [HSA:5172] [KO:K14702] (DFNB4) FOXI1 [HSA:2299] [KO:K09401] (DFNB4) KCNJ10 [HSA:3766] [KO:K05003] (DFNB6) TMIE [HSA:259236] [KO:K23907] (DFNB7/11) TMC1 [HSA:117531] [KO:K21988] (DFNB8/10) TMPRSS3 [HSA:64699] [KO:K09634] (DFNB9) OTOF [HSA:9381] [KO:K19949] (DFNB12) CDH23 [HSA:64072] [KO:K06813] (DFNB12) ATP2B2 [HSA:491] [KO:K05850] (DFNB15) GIPC3 [HSA:126326] [KO:K20056] (DFNB16) STRC [HSA:161497] [KO:K24636] (DFNB18A) USH1C [HSA:10083] [KO:K21877] (DFNB18B) OTOG [HSA:340990] [KO:K25030] (DFNB21) TECTA [HSA:7007] [KO:K18273] (DFNB22) OTOA [HSA:146183] [KO:K25029] (DFNB23) PCDH15 [HSA:65217] [KO:K16500] (DFNB24) RDX [HSA:5962] [KO:K05762] (DFNB25) GRXCR1 [HSA:389207] [KO:K17479] (DFNB26) GAB1 [HSA:2549] [KO:K09593] (DFNB26) METTL13 [HSA:51603] [KO:K25166] (DFNB28) TRIOBP [HSA:11078] [KO:K23751] (DFNB29) CLDN14 [HSA:23562] [KO:K06087] (DFNB30) MYO3A [HSA:53904] [KO:K08834] (DFNB31) WHRN [HSA:25861] [KO:K21879] (DFNB32) CDC14A [HSA:8556] [KO:K06639] (DFNB35) ESRRB [HSA:2103] [KO:K08553] (DFNB36) ESPN [HSA:83715] [KO:K24047] (DFNB37) MYO6 [HSA:4646] [KO:K10358] (DFNB39) HGF [HSA:3082] [KO:K05460] (DFNB42) ILDR1 [HSA:286676] [KO:K25781] (DFNB44) ADCY1 [HSA:107] [KO:K08041] (DFNB48) CIB2 [HSA:10518] [KO:K23837] (DFNB49) MARVELD2 [HSA:153562] [KO:K17291] (DFNB53) COL11A2 [HSA:1302] [KO:K19721] (DFNB57) PDZD7 [HSA:79955] [KO:K21882] (DFNB59) PJVK [HSA:494513] [KO:K22147] (DFNB61) SLC26A5 [HSA:375611] [KO:K14703] (DFNB63) LRTOMT [HSA:220074] [KO:K00545] (DFNB66) DCDC2 [HSA:51473] [KO:K23405] (DFNB67) LHFPL5 [HSA:222662] [KO:K23893] (DFNB68) S1PR2 [HSA:9294] [KO:K04292] (DFNB70) PNPT1 [HSA:87178] [KO:K00962] (DFNB74) MSRB3 [HSA:253827] [KO:K07305] (DFNB76) SYNE4 [HSA:163183] [KO:K23401] (DFNB77) LOXHD1 [HSA:125336] [KO:K24822] (DFNB79) TPRN [HSA:286262] [KO:K24164] (DFNB82) GPSM2 [HSA:29899] [KO:K15837] (DFNB84A) PTPRQ [HSA:374462] [KO:K16910] (DFNB84B) OTOGL [HSA:283310] [KO:K25030] (DFNB86) TBC1D24 [HSA:57465] [KO:K21841] (DFNB88) ELMOD3 [HSA:84173] [KO:K23538] (DFNB89) KARS1 [HSA:3735] [KO:K04567] (DFNB91) SERPINB6 [HSA:5269] [KO:K13963] (DFNB93) CABP2 [HSA:51475] [KO:K23531] (DFNB94) NARS2 [HSA:79731] [KO:K01893] (DFNB97) MET [HSA:4233] [KO:K05099] (DFNB98) TSPEAR [HSA:54084] [KO:K24437] (DFNB99) TMEM132E [HSA:124842] [KO:K17599] (DFNB100) PPIP5K2 [HSA:23262] [KO:K13024] (DFNB101) GRXCR2 [HSA:643226] [KO:K24294] (DFNB102) EPS8 [HSA:2059] [KO:K17277] (DFNB103) CLIC5 [HSA:53405] [KO:K05025] (DFNB104) RIPOR2 [HSA:9750] [KO:K24818] (DFNB106) EPS8L2 [HSA:64787] [KO:K17277] (DFNB107) WBP2 [HSA:23558] [KO:K22524] (DFNB108) ROR1 [HSA:4919] [KO:K05122] (DFNB109) ESRP1 [HSA:54845] [KO:K14947] (DFNB110) COCH [HSA:1690] [KO:K23574] (DFNB111) MPZL2 [HSA:10205] [KO:K27316] (DFNB112) BDP1 [HSA:55814] [KO:K15198] (DFNB113) CEACAM16 [HSA:388551] [KO:K06499] (DFNB114) GRAP [HSA:10750] [KO:K23694] (DFNB115) SPNS2 [HSA:124976] [KO:K23677] (DFNB116) CLDN9 [HSA:9080] [KO:K06087] (DFNB117) CLRN2 [HSA:645104] [KO:K23841] (DFNB119) SPATA5L1 [HSA:79029] [KO:K26051] (DFNB120) MINAR2 [HSA:100127206] [KO:K24830] (DFNB121) GPR156 [HSA:165829] [KO:K04617] (DFNB122) TMTC4 [HSA:84899] [KO:K23424] (DFNB123) STX4 [HSA:6810] [KO:K13502] (DFNB124) PKHD1L1 [HSA:93035] |
|
H00937 | Precocious puberty | ... hand, it has been reported that heterozygous mutations of the LHCGR gene cause gonadotropin-independent precocious puberty in males, but have no detectable effects on prepubertal or postpubertal females. | Endocrine and metabolic disease |
(CEPREPU) KISS1R [HSA:84634] [KO:K08374] (FMPP) LHCGR [HSA:3973] [KO:K04248] |
|
H01524 | DiGeorge syndrome | ... notably 10p13. Approximately 17% of patients with the phenotypic features of this syndrome have no detectable genomic deletion. Several mutations in TBX1 have been identified recently in non-deleted patients ... | Primary immunodeficiency | TBX1 [HSA:6899] [KO:K10175] | |
H01585 | Autoimmune hemolytic anemia | ... life-threatening anemia. The diagnosis is usually simple, based on the presence of hemolytic anemia and serological evidence of anti-erythrocyte antibodies, detectable by the direct antiglobulin test (DAT). | Hematologic disease | ||
H01626 | Arteriosclerosis obliterans | ... as well as the measurement of circulating hs-CRP levels. However, these examinations can only be detectable when ASO already developed, and there was no predictable markers for ASO in its earlier stages ... | Cardiovascular disease | ||
H01683 | Disorders of antidiuretic hormone (ADH) secretion | ... neurogenic DI) or inadequate renal response to AVP (nephrogenic DI). On the other hand, the dilutional hyponatraemia of SIADH develops due to persistent detectable or elevated plasma AVP concentrations. | Endocrine and metabolic disease | AVPR2 [HSA:554] [KO:K04228] | |
H01705 | Bilateral sudden sensorineural hearing loss | Bilateral sudden sensorineural hearing loss (SNHL) represents a rare disease entity, constituting less than 5 % of all sudden SNHL cases. Unlike unilateral disease, bilateral sudden SNHL appears to be ... | Nervous system disease |
ACTG1 [HSA:71] [KO:K05692] CDH23 [HSA:64072] [KO:K06813] COCH [HSA:1690] [KO:K23574] KCNQ4 [HSA:9132] [KO:K04929] TECTA [HSA:7007] [KO:K18273] TMPRSS3 [HSA:64699] [KO:K09634] WFS1 [HSA:7466] [KO:K14020] |
|
H01909 | Hypoinsulinemic hypoglycemia with hemihypertrophy | ... syndrome [DS:H00713] and persistent hypoketotic, hypofattyacidemic hypoinsulinaemic hypoglycemia with no detectable incompletely processed high molecular weight IGF-II precursor proteins or insulin autoantibodies ... | Inherited metabolic disorder | AKT2 [HSA:208] [KO:K04456] | |
H02037 |
Laron syndrome Growth hormone insensitivity syndrome Pituitary dwarfism II |
... functioning of the GH-IGF1 signalling pathway. The main phenotypic feature is dwarfism, noticeable from birth. Patients have an elevated level of GH and undetectable, or very low IGF1 concentrations in serum. | Endocrine and metabolic disease | GHR [HSA:2690] [KO:K05080] | |
H02212 | Familial infantile myoclonic epilepsy | ... Idiopathic epilepsies are a group of disorders characterized by recurrent seizures in the absence of detectable brain lesions or metabolic abnormalities. Recently, mutations in TBC1D24, an ARF6-interacting ... | Nervous system disease | TBC1D24 [HSA:57465] [KO:K21841] |
[ KEGG | DISEASE | DRUG | MEDICUS ] |